BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 37153665)

  • 1. Modulation of the gut-brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis.
    Hong D; Zhang C; Wu W; Lu X; Zhang L
    Front Neurol; 2023; 14():1133546. PubMed ID: 37153665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
    Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
    Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach.
    Rajanala K; Kumar N; Chamallamudi MR
    Curr Neuropharmacol; 2021; 19(7):990-1006. PubMed ID: 33327916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and gut-microbiota-brain axis: A narrative review.
    Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
    J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Microbiota-Gut-Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases.
    Obrenovich M; Jaworski H; Tadimalla T; Mistry A; Sykes L; Perry G; Bonomo RA
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32456229
    [No Abstract]   [Full Text] [Related]  

  • 8. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
    Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
    BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment.
    Dziedzic A; Saluk J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
    Carabotti M; Scirocco A; Maselli MA; Severi C
    Ann Gastroenterol; 2015; 28(2):203-209. PubMed ID: 25830558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions.
    Chen S; Cai X; Lao L; Wang Y; Su H; Sun H
    Aging Dis; 2024 Feb; 15(1):74-95. PubMed ID: 37307822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gut microbiota on neurodegenerative diseases.
    Khatoon S; Kalam N; Rashid S; Bano G
    Front Aging Neurosci; 2023; 15():1145241. PubMed ID: 37323141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
    Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
    Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance.
    Tiwari P; Dwivedi R; Bansal M; Tripathi M; Dada R
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
    Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
    J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders.
    Geng ZH; Zhu Y; Li QL; Zhao C; Zhou PH
    Front Aging Neurosci; 2022; 14():810483. PubMed ID: 35517052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.
    Martin S; Battistini C; Sun J
    Front Cell Infect Microbiol; 2022; 12():839526. PubMed ID: 35360111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis.
    Mandrioli J; Amedei A; Cammarota G; Niccolai E; Zucchi E; D'Amico R; Ricci F; Quaranta G; Spanu T; Masucci L
    Front Neurol; 2019; 10():1021. PubMed ID: 31620079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.